Children are the heart of the fears around a possible third wave of Covid-19 in India.

State governments, including those in Delhi and Maharashtra, have been raising alarm over pediatric capacities in hospitals and vaccines. Indian vaccine maker Bharat Biotech’s Covaxin has already recruited volunteers for trials in the 12-18 years age group, and will soon begin signing up kids in the 6-12 years bracket.